Curcumin Administered as Micellar Solution Suppresses Intestinal Inflammation and Colorectal Carcinogenesis

References

• Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi REM, Corcione F. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016; 68(1):7–11. doi:10.1007/s13304-016-0359-y
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019; 16(12):713–32. doi:10.1038/s41575-019-0189-8
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008; 25(9):2097–116. doi:10.1007/s11095-008-9661-9
   PubMed Web of Science ®Google Scholar
• Murphy N, Moreno V, Hughes DJ, Vodicka L, Vodicka P, Aglago EK, Gunter MJ, Jenab M. Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol Aspects Med. 2019; 69:2–9. doi:10.1016/j.mam.2019.06.005
   PubMed Web of Science ®Google Scholar
• Valle L, Vilar E, Tavtigian SV, Stoffel EM. Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine. J Pathol. 2019; 247(5):574–88. doi:10.1002/path.5229
   PubMed Web of Science ®Google Scholar
• Bouvard V, Loomis D, Guyton KZ, Grosse Y, Ghissassi FE, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K. International Agency for Research on Cancer Monograph Working G: Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015; 16(16):1599–600. doi:10.1016/S1470-2045(15)00444-1
   PubMed Web of Science ®Google Scholar
• Seiwert N, Heylmann D, Hasselwander S, Fahrer J. Mechanism of colorectal carcinogenesis triggered by heme iron from red meat. Biochim Biophys Acta Rev Cancer. 2020; 1873(1):188334doi:10.1016/j.bbcan.2019.188334
   PubMed Web of Science ®Google Scholar
• Venturelli S, Burkard M, Biendl M, Lauer UM, Frank J, Busch C. Prenylated chalcones and flavonoids for the prevention and treatment of cancer. Nutrition. 2016; 32(11-12):1171–8. doi:10.1016/j.nut.2016.03.020
   PubMed Web of Science ®Google Scholar
• Burkard M, Leischner C, Lauer UM, Busch C, Venturelli S, Frank J. Dietary flavonoids and modulation of natural killer cells: implications in malignant and viral diseases. J Nutr Biochem. 2017; 46:1–12. doi:10.1016/j.jnutbio.2017.01.006
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009; 41(1):40–59. doi:10.1016/j.biocel.2008.06.010
   PubMed Web of Science ®Google Scholar
• Shehzad A, Khan S, Shehzad O, Lee YS. Curcumin therapeutic promises and bioavailability in colorectal cancer. Drugs Today. 2010; 46(7):523–32. doi:10.1358/dot.2010.46.7.1509560
   PubMed Web of Science ®Google Scholar
• Kasi PD, Tamilselvam R, Skalicka-Woźniak K, Nabavi SF, Daglia M, Bishayee A, Pazoki-Toroudi H, Nabavi SM. Molecular targets of curcumin for cancer therapy: an updated review. Tumour Biol. 2016; 37(10):13017–28. doi:10.1007/s13277-016-5183-y
   PubMedGoogle Scholar
• Bortel N, Armeanu-Ebinger S, Schmid E, Kirchner B, Frank J, Kocher A, Schiborr C, Warmann S, Fuchs J, Ellerkamp V, et al. Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways. Oncotarget. 2015; 6(38):40680–91. doi:10.18632/oncotarget.5673
   PubMedGoogle Scholar
• Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother. 2017; 85:102–12. doi:10.1016/j.biopha.2016.11.098
   PubMed Web of Science ®Google Scholar
• Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal. 2008; 10(3):511–45. doi:10.1089/ars.2007.1769
   PubMed Web of Science ®Google Scholar
• Allegra A, Innao V, Russo S, Gerace D, Alonci A, Musolino C. Anticancer activity of curcumin and its analogues: preclinical and clinical studies. Cancer Invest. 2017; 35(1):1–22. doi:10.1080/07357907.2016.1247166
   PubMed Web of Science ®Google Scholar
• Aller LL. What about bioavailability of oral curcumin?. CMAJ. 2019; 191(15):E427doi:10.1503/cmaj.71708
   PubMed Web of Science ®Google Scholar
• Garg AX, Curcumin AAA AKI Investigators, Moist L, Pannu N, Tobe S, Walsh M, Weir M. Curcumin AAAAKII: Bioavailability of oral curcumin. CMAJ. 2019; 191(15):E428doi:10.1503/cmaj.71719
   PubMed Web of Science ®Google Scholar
• Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014; 46(1):2–18. doi:10.4143/crt.2014.46.1.2
   PubMed Web of Science ®Google Scholar
• Metzler M, Pfeiffer E, Schulz SI, Dempe JS. Curcumin uptake and metabolism. Biofactors. 2013; 39(1):14–20. doi:10.1002/biof.1042
   PubMed Web of Science ®Google Scholar
• Tonnesen HH: Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids. Die Pharmazie. 2002; 57(12):820–4.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, Zhai G. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016; 24(8):694–702. doi:10.3109/1061186X.2016.1157883
   PubMed Web of Science ®Google Scholar
• Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res. 2014; 58(3):516–27. doi:10.1002/mnfr.201300724
   PubMed Web of Science ®Google Scholar
• Kocher A, Bohnert L, Schiborr C, Frank J. Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals. Mol Nutr Food Res. 2016; 60(7):1555–63. doi:10.1002/mnfr.201501034
   PubMed Web of Science ®Google Scholar
• Dützmann S, Schiborr C, Kocher A, Pilatus U, Hattingen E, Weissenberger J, Geßler F, Quick-Weller J, Franz K, Seifert V, et al. Intratumoral concentrations and effects of orally administered micellar curcuminoids in glioblastoma patients. Nutr Cancer. 2016; 68(6):943–8. doi:10.1080/01635581.2016.1187281
   PubMed Web of Science ®Google Scholar
• Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, Neurath MF. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017; 12(7):1295–309. doi:10.1038/nprot.2017.044
   PubMed Web of Science ®Google Scholar
• Wirtz S, Nagel G, Eshkind L, Neurath MF, Samson LD, Kaina B. Both base excision repair and O6-methylguanine-DNA methyltransferase protect against methylation-induced colon carcinogenesis. Carcinogenesis. 2010; 31(12):2111–7. doi:10.1093/carcin/bgq174
   PubMed Web of Science ®Google Scholar
• Dörsam B, Seiwert N, Foersch S, Stroh S, Nagel G, Begaliew D, Diehl E, Kraus A, McKeague M, Minneker V, et al. PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression. Proc Natl Acad Sci Usa. 2018; 115(17):E4061–E4070. doi:10.1073/pnas.1712345115
   PubMed Web of Science ®Google Scholar
• Fahrer J, Frisch J, Nagel G, Kraus A, Dörsam B, Thomas AD, Reißig S, Waisman A, Kaina B. DNA repair by MGMT, but not AAG, causes a threshold in alkylation-induced colorectal carcinogenesis. Carcinogenesis. 2015; 36(10):1235–44. doi:10.1093/carcin/bgv114
   PubMed Web of Science ®Google Scholar
• Chartier LC, Howarth GS, Lawrance IC, Trinder D, Barker SJ, Mashtoub S. Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer. Dig Dis Sci. 2018; 63(1):135–45. doi:10.1007/s10620-017-4876-4
   PubMed Web of Science ®Google Scholar
• Bugni JM, Meira LB, Samson LD. Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins. Oncogene. 2009; 28(5):734–41. doi:10.1038/onc.2008.426
   PubMed Web of Science ®Google Scholar
• Becker C, Fantini MC, Neurath MF. High resolution colonoscopy in live mice. Nat Protoc. 2006; 1(6):2900–4. doi:10.1038/nprot.2006.446
   PubMed Web of Science ®Google Scholar
• Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 2008; 267(1):133–64. doi:10.1016/j.canlet.2008.03.025
   PubMed Web of Science ®Google Scholar
• Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 1994; 54(22):5841–7.
   PubMed Web of Science ®Google Scholar
• Kubota M, Shimizu M, Sakai H, Yasuda Y, Terakura D, Baba A, Ohno T, Tsurumi H, Tanaka T, Moriwaki H, et al. Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice. Nutr Cancer. 2012; 64(1):72–9. doi:10.1080/01635581.2012.630554
   PubMed Web of Science ®Google Scholar
• McFadden R-MT, Larmonier CB, Shehab KW, Midura-Kiela M, Ramalingam R, Harrison CA, Besselsen DG, Chase JH, Caporaso JG, Jobin C, et al. The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflamm Bowel Dis. 2015; 21(11):2483–94. doi:10.1097/MIB.0000000000000522
   PubMed Web of Science ®Google Scholar
• Volate SR, Davenport DM, Muga SJ, Wargovich MJ. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis. 2005; 26(8):1450–6. doi:10.1093/carcin/bgi089
   PubMed Web of Science ®Google Scholar
• Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 1999; 59(3):597–601.
   PubMed Web of Science ®Google Scholar
• Alizadeh AM, Khaniki M, Azizian S, Mohaghgheghi MA, Sadeghizadeh M, Najafi F. Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier–curcumin. Eur J Pharmacol. 2012; 689(1-3):226–32. doi:10.1016/j.ejphar.2012.06.016
   PubMed Web of Science ®Google Scholar
• Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011; 4(3):354–64. doi:10.1158/1940-6207.CAPR-10-0098
   PubMed Web of Science ®Google Scholar
• Hagl S, Kocher A, Schiborr C, Kolesova N, Frank J, Eckert GP. Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice - Impact on bioavailability. Neurochem Int. 2015; 89:234–42. doi:10.1016/j.neuint.2015.07.026
   PubMed Web of Science ®Google Scholar
• Kaina B, Christmann M, Naumann S, Roos WP. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst). 2007; 6(8):1079–99. doi:10.1016/j.dnarep.2007.03.008
   PubMed Web of Science ®Google Scholar
• Fahrer J, Kaina B. Impact of DNA repair on the dose-response of colorectal cancer formation induced by dietary carcinogens. Food Chem Toxicol. 2016; 106(Pt B):583–594.
   PubMed Web of Science ®Google Scholar
• Fu D, Calvo JA, Samson LD. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer. 2012; 12(2):104–20. doi:10.1038/nrc3185
   PubMed Web of Science ®Google Scholar
• Margison GP, Povey AC, Kaina B, Santibáñez Koref MF. Santibanez Koref MF: Variability and regulation of O6-alkylguanine-DNA alkyltransferase. Carcinogenesis. 2003; 24(4):625–35. doi:10.1093/carcin/bgg005
   PubMed Web of Science ®Google Scholar
• Janssen K, Eichhorn-Grombacher U, Schlink K, Nitzsche S, Oesch F, Kaina B. Long-time expression of DNA repair enzymes MGMT and APE in human peripheral blood mononuclear cells. Arch Toxicol. 2001; 75(5):306–12. doi:10.1007/s002040100226
   PubMed Web of Science ®Google Scholar
• Fahrer J, Kaina B. O6-methylguanine-DNA methyltransferase in the defense against N-nitroso compounds and colorectal cancer. Carcinogenesis. 2013; 34(11):2435–42. doi:10.1093/carcin/bgt275
   PubMed Web of Science ®Google Scholar
• Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 2000; 60(9):2368–71.
   PubMed Web of Science ®Google Scholar
• Lind GE, Thorstensen L, Løvig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer. 2004; 3:28doi:10.1186/1476-4598-3-28
   PubMed Web of Science ®Google Scholar
• Meira LB, Bugni JM, Green SL, Lee C-W, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, McFaline JL, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest. 2008; 118(7):2516–25. doi:10.1172/JCI35073
   PubMed Web of Science ®Google Scholar
• Kwon Y. Estimation of curcumin intake in Korea based on the Korea National Health and Nutrition Examination Survey (2008-2012). Nutr Res Pract. 2014; 8(5):589–94. doi:10.4162/nrp.2014.8.5.589
   PubMed Web of Science ®Google Scholar
• Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016; 7(2):27–31. doi:10.4103/0976-0105.177703
   PubMedGoogle Scholar